THORATEC LABORATORIES CORP
10-C, 1996-07-09
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: REPUBLIC INDUSTRIES INC, 8-K/A, 1996-07-09
Next: INTERFERON SCIENCES INC, 4, 1996-07-09



<PAGE>   1
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                   FORM 10-C

                REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
                          INTERDEALER QUOTATION SYSTEM
                  FILED PURSUANT TO SECTION 13 OR 15(d) OF THE
                SECURITIES EXCHANGE ACT OF 1934 AND RULE 13a-17
                              OR 15d-17 THEREUNDER

                       Thoratec Laboratories Corporation
- --------------------------------------------------------------------------------
                 (Exact name of issuer as specified in charter)

                 2023 Eighth Street, Berkeley, California 94710
- --------------------------------------------------------------------------------
                    (Address of principal executive offices)

                                               
Issuer's telephone number, including area code          (510) 841-1213
                                               ---------------------------------

                   I. CHANGE IN NUMBER OF SHARES OUTSTANDING

Indicate any change (increase or decrease) of five percent or more in the
number of shares outstanding:

1. Title of security            Common Stock, no par value
                     -----------------------------------------------------------

2. Number of shares outstanding before the change       16,274,146
                                                  ------------------------------

3. Number of shares outstanding after the change        17,774,146
                                                 -------------------------------

4. Effective date of change     July 2, 1996
                            ----------------------------------------------------

5. Method of change: Specify method (such as merger, acquisition, exchange, 
                     distribution, stock split, reverse split, acquisition of 
                     stock for treasury, etc.)

     public offering
- --------------------------------------------------------------------------------

Give brief description of transaction   public offering of 1,500,000 shares
                                      ------------------------------------------
     of Common Stock
- --------------------------------------------------------------------------------

                          II. CHANGE IN NAME OF ISSUER

1. Name prior to change
                        --------------------------------------------------------

2. Name after change 
                     -----------------------------------------------------------

3. Effective date of charter amendment changing name 
                                                     ---------------------------

4. Date of shareholder approval of change, if required 
                                                       -------------------------

Date    July 5, 1996                                 /s/ Cheryl Hess
     -----------------------------------  --------------------------------------
                                              (Officer's signature and title)
                                             Cheryl D. Hess, CFO, VP - Finance
                                                       and Secretary
                                                (Bulletin No. 153, 10-08-93)


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission